Boiron S.A.
Boiron S.A. (BOIRF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
boirf · pe ratio · data through Dec 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Boiron S.A. (BOIRF) measures how much investors pay for each dollar of the company's trailing earnings. BOIRF's current PE ratio of 15.51x is calculated by dividing its stock price of $31.90 by its TTM earnings per share of $1.85. −38.9% discount vs 5Y avg 25.4x
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31
PE Ratio History
2005 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 20 fiscal years · Front-end computedMinQ1 · 25%16.2x
MedianQ3 · 75%42.2x
Max
At 15.51x, BOIRF's current P/E is within its average historical range over the past 20 fiscal years.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Boiron S.A.You BOIRF | $554M | 15.51x | -10.9% | $1.85 |
 Allergy Therapeutics plc AGYTF | $655M | N/A | — | -$0.01 |
 Beijing Tong Ren Tang Chinese Medicine Company Limited BJTRF | $536M | 10.64x | -38.9% | $0.47 |
 CellaVision AB (publ) CLVSF | $322M | 24.18x | +38.9% | $6.42 |
 Elite Pharmaceuticals, Inc. ELTP | $399M | N/A | — | -$0.00 |
 Glass House Brands Inc. GLASF | $1.0B | N/A | — | -$0.40 |
 ManifestSeven Holdings Corporation MNFSF | $0M | N/A | — | -$0.78 |
Industry Average 2 peers with valid PE | — | 17.41x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-12-31Latest FY2024 | 42.15x | $0.65 | +126.0% | |
2023-12-31 FY2023 | 18.65x | $2.06 | +18.3% | |
2022-12-31 FY2022 | 15.77x | $2.57 | -34.3% | |
2021-12-31 FY2021 | 24.00x | $1.63 | -8.6% | |
2020-12-31 FY2020 | 26.26x | $1.50 | +94.7% | |
2019-12-31 FY2019 | 13.49x | $2.32 | -7.0% | |
2018-12-31 FY2018 | 14.51x | $3.23 | -17.4% | |
2017-12-31 FY2017 | 17.56x | $4.25 | -15.2% | |
2016-12-31 FY2016 | 20.72x | $4.22 | -20.6% | |
2015-12-31 FY2015 | 26.09x | $4.01 | +56.4% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Boiron S.A. (BOIRF) measures how much investors pay for each dollar of the company's trailing earnings. BOIRF's current PE ratio of 15.51x is calculated by dividing its stock price of $31.90 by its TTM earnings per share of $1.85.
Frequently asked questions
BOIRF pe ratio · 6 questionsBOIRF's current PE ratio is 15.51x as of 2026-06-09, based on a stock price of $31.90 and TTM EPS of $1.85. Data sourced from Financial Modeling Prep via BOIRF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Boiron S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09